FDA Inspection 1098879 — Qilu SYNVA Pharmaceutical Co. Ltd
The FDA completed an inspection of Qilu SYNVA Pharmaceutical Co. Ltd on July 26, 2019 in Dezhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 26, 2019
- Fiscal Year
- 2019
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Dezhou (China)